COGENT BIOSCIENCES INC (COGT) Stock Income Statement
NASDAQ:COGT - Nasdaq - US19240Q2012 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 288.00M | 276.00M | 208.00M | 147.84M | 75.55M | |||
| Research and Development | N/A | N/A | 173.75M | 121.63M | 55.91M | |||
| Selling, General, and Administrative Expenses | 46.00M | 43.00M | 34.00M | 26.21M | 19.64M | |||
| Operating Income | -288.00M | -276.00M | -208.00M | -147.84M | -75.55M | |||
| Interest Income/Expense | N/A | N/A | 13.08M | 3.99M | 470.00K | |||
| Other Income/Expense | 4.99M | 20.00M | 2.64M | 4.01M | 2.81M | |||
| Non Recurring Items | N/A | N/A | N/A | -400.00K | N/A | |||
| Income Before Taxes | -270.00M | -256.00M | -192.00M | -140.24M | -72.27M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -202.00M | -201.00M | -155.00M | -140.24M | -72.27M | |||
| EBITDA | -285.51M | -273.55M | -205.73M | -147.00M | -75.40M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.87 | -1.94 | -1.94 | -2.39 | -1.87 | |||
| Non GAAP EPS | -1.87 | -1.97 | -2.40 | -2.45 | -1.85 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD